The University of Iowa Hospitals and Clinics, located in Iowa City, Iowa, has been added as a clinical site that is participating in the INSPIRE Study, conducted by InVivo Therapeutics Holdings Corp, makers of the Neuro-Spinal Scaffold Implant.
With this addition, there are now 27 clinical sites participating in the INSPIRE (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold or Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury) study:

  • Allegheny General Hospital, Pittsburgh,
  • Banner University Medical Center, Tucson, Ariz
  • Barnes-Jewish Hospital at Washington University Medical Center, St Louis
  • Barrow Neurological Institute – St. Joseph’s Hospital and Medical Center, Phoenix
  • Ben Taub Hospital/Baylor College of Medicine, Houston
  • Beth Israel Deaconess Medical Center, Boston
  • Carolina Neurosurgery and Spine Associates/Carolinas Rehabilitation, Charlotte, NC
  • Cooper Neurological Institute, Camden, NJ
  • Foothills Medical Centre, Calgary, AB, Canada
  • Goodman Campbell Brain and Spine/Indiana University Health Neuroscience Center, Indianapolis
  • Hospital of the University of Pennsylvania, Philadelphia
  • Keck Hospital of University of Southern California, Los Angeles
  • Medical College of Wisconsin/Froedtert Hospital, Milwaukee
  • Mount Sinai Hospital, New York
  • Northwestern Medicine, Chicago
  • Oregon Health & Science University, Portland, Ore
  • Rutgers New Jersey Medical School, Newark, NJ
  • Thomas Jefferson University Hospital, Philadelphia
  • Toronto Western Hospital, Toronto
  • University of California, Davis Medical Center, Sacramento, Calif
  • University of California, San Diego Medical Center, San Diego
  • University of Iowa Hospitals and Clinics, Iowa City, Iowa
  • University of Kansas Medical Center, Kansas City, Kan
  • University of Louisville Hospital, Louisville, Ky
  • University of Pittsburgh Medical Center Presbyterian, Pittsburgh
  • University of Virginia Health System, Charlottesville, Va
  • Vidant Medical Center, Greenville, NC

“Two active areas of spinal cord injury research involve timing and the use of biomaterials. The INSPIRE study represents the marriage of these two concepts and we look forward to participating,” says Patrick Hitchon, MD, professor in the departments of Neurosurgery and Biomedical Engineering and Principal Investigator at the study site, in a media release from InVivo Therapeutics Holdings Corp.
“We welcome Dr Hitchon and his team to the INSPIRE study. This is the fourth new site we have announced in the last 3 weeks, and we look forward to bringing on more high-quality sites over the next several months,” states Mark Perrin, InVivo’s CEO and chairman, in the release.
[Source(s): InVivo Therapeutics Holdings Corp, Business Wire]